$47.97
1.523.27%
Last update: Nov 9, 4:00 PM
AnaptysBio Inc
ANABNASDAQ
AnaptysBio rose 111.8% from $22.65 to $47.97, ahead of the S&P 500's +10.5%. Its worst day was Jul 20 (−13.3%), and its low came Nov 12 at $22.06.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
AnaptysBio closed at its lowest level of the year, 2.6% below where the year started.
−1.4% · S&P 500 +0.1%
AnaptysBio shares rose 9.8%, while the S&P 500 rose 0.2%.
+9.8% · S&P 500 +0.2%
Story events cover the past 12 months · Times ET
AnaptysBio shares rose 10.0%, while the S&P 500 fell 0.0%.
+10.0% · S&P 500 0.0%
EPS of $1.58 beat the $0.92 estimate on $108.2M revenue (est. $86.0M).
+14.6% · S&P 500 +0.7%
AnaptysBio shares fell 11.7%, while the S&P 500 fell 1.7%.
−11.7% · S&P 500 −1.7%
AnaptysBio shares rose 14.8%, while the S&P 500 rose 0.8%.
+14.8%, the year's best day · S&P 500 +0.8%
EPS of $-1.84 missed the $-0.66 estimate on $25.6M revenue (est. $18.9M).
−4.4% · S&P 500 +0.6%
AnaptysBio closed at its highest level of the year, 208.2% above where the year started.
+5.2% · S&P 500 −0.8%
EPS of $-0.11 beat the $-0.46 estimate on $27.5M revenue (est. $21.7M).
−1.8% · S&P 500 0.0%
Where it ended: a close of $47.97 on Nov 9, 2026. Up next: Q3 2026 earnings on Nov 24, 2026 (EPS est. $0.51, revenue est. $33.2M).
Nothing in the past 12 months.
All ANAB dividend historyReplay the year: the line draws itself and stops at each of the 9 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for ANAB and SPY from Benzinga historical bars. Not investment advice.
